Literature DB >> 33378201

Enantioselective Alkylamination of Unactivated Alkenes under Copper Catalysis.

Zibo Bai1, Heng Zhang1, Hao Wang1, Hanrui Yu1, Gong Chen1, Gang He1.   

Abstract

An enantioselective addition reaction of various alkyl groups to unactivated internal alkenes under Cu catalysis has been developed. The reaction uses amide-linked aminoquinoline as the directing group, 4-alkyl Hantzsch esters as the donor of alkyl radicals, and rarely used biaryl diphosphine oxide as a chiral ligand. β-lactams featuring two contiguous stereocenters at Cβ and the β substituent can be obtained in good yield with excellent enantioselectivity. Mechanistic studies indicate that a nucleophilic addition of the alkyl radical to CuII-coordinated alkene is the enantio-determining step.

Entities:  

Year:  2020        PMID: 33378201     DOI: 10.1021/jacs.0c12333

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  4 in total

1.  Modular synthesis of non-conjugated N-(quinolin-8-yl) alkenyl amides via cross-metathesis.

Authors:  Hui-Qi Ni; Zi-Qi Li; Van T Tran; Keary M Engle
Journal:  Tetrahedron       Date:  2021-06-12       Impact factor: 2.388

2.  Divergent regioselective Heck-type reaction of unactivated alkenes and N-fluoro-sulfonamides.

Authors:  Chunyang Zhao; Yang Li; Yujiao Dong; Miao Li; Dan Xia; Shuangqiu Gao; Qian Zhang; Qun Liu; Wei Guan; Junkai Fu
Journal:  Nat Commun       Date:  2022-10-22       Impact factor: 17.694

3.  Copper(i)-catalyzed radical carboamination reaction of 8-aminoquinoline-oriented buteneamides with chloroform: synthesis of-β-lactams.

Authors:  Zixu Gan; Ke Zhang; Peng Shi; Yingsheng Zhao; Runsheng Zeng
Journal:  RSC Adv       Date:  2021-08-19       Impact factor: 4.036

4.  Enantioselective α-Arylation of Ketones via a Novel Cu(I)-Bis(phosphine) Dioxide Catalytic System.

Authors:  Margarita Escudero-Casao; Giulia Licini; Manuel Orlandi
Journal:  J Am Chem Soc       Date:  2021-02-26       Impact factor: 15.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.